Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen · Real Estate · REIT - Industrial

Prologis logoPrologis

PLD · a US exchange · USD · Market cap $126.5B · 2,802 employees

Prologis, Inc.

FAIL · Does not pass the screen
128.67 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price128.67 USD at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 2.11)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $103.02 to $118.47, base estimate $103.02 (screen dated 2026-11-13).

Current read
Accumulation ?
Overvalued · screened 2026-11-13
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning political buying, disclosed 2026-10-15
  • Options put/call open interest 2.11, read 2026-11-13
  • Ethical does not pass the values gate
Price128.67 USD
Fair value103.02
Ethical score10.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-12Read Distribution130.03-1.0% to today ✓Markup gives way to Distribution first Distribution read since October
2026-11-05Read Markup131.36-2.0% to today Distribution gives way to Markup
2026-10-22Read Distribution126.94+1.4% to today Markdown gives way to Distribution after an 8% slide in 6 weeks
2026-09-09Read Markdown138.48-7.1% to today ✓Distribution gives way to Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Prologis holds its Accumulation at $128.67. Consolidating, no directional conviction, held for 344 days.

As held on the ledger · 2026-11-13
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 344 days
Price at the screen$128.67
Valuation28.66 trailing · 36.11 forward price to earnings
Values screenFAIL · score 10.0
Beta1.29
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 36.14% Below 33% Interest-bearing debt is 36.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 11.24% Below 33% Cash held in interest-bearing accounts and securities is 11.2% of assets, under the one-third limit. Pass
Receivables 1.77% Below 49% Money owed to the company is 1.8% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Prologis's business is in a permissible area, but its interest-bearing debt is about 36% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PLD's ethical verdict changes

Today PLD does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $103.02 fair value estimate, narrow competitive moat, 10.20% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

103.02Conservative103.02Base case118.47Growth case 128.67Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 24.9% above the base estimate.

The Street's Range
136.00Street low 151.50Street average 170.00Street high 128.67Price

Third-party analyst targets: 14 covering, consensus Buy. The average target sits +18% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $103.02, with a range of $103.02 to $118.47, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 36.1x forward earnings, the price already runs ahead of the business. It trades 25% above our $103.02 fair value, so you would be buying at a premium, not a discount. The narrow moat is real, but quality alone does not make an expensive price cheap.

The fundamentals · plain-English read
Forward P/E36.1xexpensive even after accounting for its growth
Trailing P/E28.7xa premium valuation
EPS, trailing4.54
EPS, forward3.60
Revenue growth+10.2%steady growth
Profit margin43.1%highly profitable on every dollar of sales
Return on equity7.7%a modest return on shareholder capital
FCF yield4.49%
Dividend yield2.93%
Debt to equity0.62moderate, manageable leverage
Current ratio0.73below 1: short-term bills exceed liquid assets
Beta1.29moves a little more than the market
Short interest, float0.02%
52-week range121.40 - 153.35
MoatNARROW
Market cap$126.5B
Employees2,802

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PLD trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Distribution · changed $130.03 -1.0% Entry 17

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151.

2026-11-05 Markup · changed $131.36 +3.9% Entry 16

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. Since the last review it dropped out of the Titan Ethical 500.

2026-10-29 Distribution $126.45 -0.4% Entry 15

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151.

2026-10-22 Distribution · changed $126.94 -2.0% Entry 14

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151.

2026-10-15 Markdown $129.49 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-14 Markdown $129.49 +0.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-13 Markdown $129.49 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-12 Markdown $129.49 -2.7% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-11 Markdown $133.05 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-10 Markdown $133.05 +0.0% Entry 8

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 38%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $151. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on PLD

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in PLD's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · PLD
DateInsiderTitleTypeSharesValue
2026-04-28 PIANI OLIVIER Director 1,984 $280,873
2026-04-28 KENNARD LYDIA H Director 1,984 ·
2026-04-28 CONNOR JAMES B Director 1,984 ·
2026-04-28 MODJTABAI AVID Director 1,984 ·
2026-04-28 LYONS IRVING F III Director 43,825 $6,202,552
2026-04-28 PIANI OLIVIER Director 1,984 ·
2026-03-31 LETTER DANIEL Chief Executive Officer 16,000 $160
2026-03-26 MOGHADAM HAMID R Director 1,019,089 ·
2026-03-09 ANDRUS CARTER Chief Operating Officer 25,106 $251
2026-01-28 SLUSSER SARAH ANN Director 111 $12,631

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming PLD
DatePoliticianPartyTypeAmount
2026-10-15 David Taylor Republican buy 1K–15K
2026-10-15 David Taylor Republican buy 1K–15K
2026-10-15 David Taylor Republican buy 1K–15K
2026-10-15 David Taylor Republican buy 1K–15K
2026-10-15 David Taylor Republican buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $144.07 +1.5% · $1,015 +1.5%
2 months $137.19 +6.6% · $1,066 +6.6%
3 months $130.85 +11.8% $1.07 $1,126 +12.6%
6 months $128.52 +13.8% $2.08 $1,154 +15.4%
1 year $105.81 +38.2% $4.10 $1,421 +42.1%
2 years $103.89 +40.8% $7.99 $1,484 +48.4%
3 years $110.25 +32.6% $11.56 $1,431 +43.1%
5 years $108.21 +35.1% $17.48 $1,513 +51.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PLD does next, these words stay.

Prologis · PLD · Accumulation · $128.67
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.